Trulicity is a once-weekly injectable medication used to improve blood sugar control in adults with type 2 diabetes. It is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means it works by mimicking the effects of a hormone called GLP-1, which is released by the gut after eating. GLP-1 helps to control blood sugar levels by slowing down the emptying of the stomach, reducing appetite, and increasing insulin production.
Trulicity is effective in lowering blood sugar levels and reducing the risk of cardiovascular events in people with type 2 diabetes. It is also well-tolerated, with the most common side effects being mild to moderate gastrointestinal symptoms, such as nausea, vomiting, and diarrhea. Trulicity is not recommended for people with type 1 diabetes or diabetic ketoacidosis.
